CtrlK
MO
NYSE
Tobacco
$71.79
USD
-$0.93 (-1.27%)
At close: Jul 10, 2026, 4:00 PM EDT
Market Cap:
$121.05B
Volume:
7.2M
Previous Close
$72.72
Day Range
$70.76 - $72.15
52 Week Range
$54.70 - $74.56
Average Volume (10 Days)
7.3M
P/E Ratio
17.42
Dividend Yield
5.79%
Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. The company is headquartered in Richmond, Virginia and currently employs 5,900 full-time employees. Its segments include smokeable products and oral tobacco products. The smokeable products segment consists of combustible cigarettes and machine-made large cigars. The oral tobacco products segment includes moist smokeless tobacco (MST) products and oral nicotine pouches. Its wholly owned subsidiaries include manufacturers of both combustible and smoke-free products. In combustibles, it owns Philip Morris USA Inc. (PM USA), and John Middleton Co. (Middleton), which are cigarette manufacturers. Its smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), a global MST manufacturer, Helix Innovations LLC (Helix), a manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio. The brand portfolios of its operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY.
CEO
Mr. William Gifford
Headquaters
Richmond, VIRGINIA, US
Founded
1923
Employees
5,900
The FDA authorized fruit-flavored e-cigarettes for adult smokers for the first time, citing the need for regulated alternatives to illegal products flooding the market. The decision comes as new research suggests vaping likely contributes to cancer risk, though long-term health effects remain uncertain due to limited data.
0
0
Altria Group exceeded profit expectations in Q1 as higher cigarette prices offset declining smoking volumes. Revenue rose 5.3% to $4.8 billion, with earnings per share of $1.32 beating analyst estimates of $1.25. The company continues expanding into oral nicotine products while maintaining its 5.8% dividend yield.
0
0
Altria's first-quarter revenue climbed 20% to $5.43 billion, surpassing analyst expectations, as the tobacco company leaned on higher cigarette prices to offset declining smoking volumes. Adjusted earnings per share of $1.32 beat estimates, while operating margins expanded sharply to 55.9%. However, cigarette shipment volumes fell 7.8%, and Marlboro's retail share declined 1.4 percentage points, highlighting ongoing structural challenges in the category.
0
0
Altria reported first-quarter revenue of $5.43 billion, surpassing analyst expectations by 18.6%, and adjusted EPS of $1.32, beating the $1.25 consensus. The gains were driven primarily by higher cigarette prices, though shipment volumes declined 7.8% year-over-year. The company reaffirmed its full-year EPS guidance while continuing to invest in oral tobacco products like on! nicotine pouches.
0
0
